http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2233173-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F13-00 |
filingDate | 1996-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd9e0e6b59e7142514971ab021fcdc76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9632f6fd320b3abc1e7e4075debc7ea6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cb3f20cc1ea4cd605fce475822f844c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9edc526f74d6f7dc0a81f8f97b203b45 |
publicationDate | 1997-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2233173-A1 |
titleOfInvention | Dopamine and serotonin transporter ligands and imaging agents |
abstract | This invention presents a series of novel tropane-based derivatives complexed with either technetium or rhenium having the formula (See formula I) with X, Z, N, and Q being specifically defined herein. These compounds are specific for central nervous system receptors, in particular, dopamine or serotonin receptors. The compounds of the invention have utility, inter alia, as imaging agents for CNS receptors. Methods of using these novel compounds as imaging agents are presented, as are intermediates and methods for making these novel compounds. |
priorityDate | 1995-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.